Contraindications for Acapella PEP Device in Chronically Tracheostomized Patients
There are no absolute contraindications to using an Acapella PEP device in a chronically tracheostomized patient, but you must avoid its use if the patient has an active pneumothorax or untreated tension pneumothorax.
Key Contraindications and Precautions
Absolute Contraindications
- Active pneumothorax: Positive expiratory pressure devices, including the Acapella, should NOT be used in patients with pneumothorax 1. The increased intrathoracic pressure can worsen air trapping and potentially convert a simple pneumothorax into a tension pneumothorax.
Relative Contraindications (Use with Extreme Caution)
- Recent pneumothorax: Even after resolution, consider withholding PEP therapy for at least 2 weeks 1
- Untreated tension pneumothorax: This is a medical emergency requiring immediate intervention before any airway clearance therapy
- Severe hemodynamic instability: PEP can decrease venous return and cardiac output 2
- Untreated hemoptysis: Active bleeding may worsen with increased airway pressures
Tracheostomy-Specific Considerations
For your chronically tracheostomized patient, the device can be safely adapted:
- The Acapella can be connected directly to the tracheostomy tube using appropriate adapters
- Ensure the tracheostomy cuff is appropriately inflated or deflated based on your clinical goals (inflated for maximum PEP effect, deflated if upper airway patency allows)
- Monitor for signs of barotrauma: subcutaneous emphysema, sudden respiratory distress, or pneumothorax 3
Clinical Monitoring Requirements
When using the Acapella device in a tracheostomy patient, watch for these "red flags" 3:
- Increasing airway pressure
- Reducing tidal volume
- Obvious air leak
- Surgical emphysema (subcutaneous air)
- Sudden deterioration in respiratory status
Evidence-Based Benefits
The Acapella device has demonstrated significant benefits in appropriate patients 4:
- Improved cough-related quality of life
- Reduced cough frequency (60 fewer coughs per 24 hours)
- Improved fatigue scores
- Enhanced sputum clearance 5, 6
The device produces oscillatory pressures of 8-21 Hz and mean pressures of 3-23 cm H₂O depending on flow rates and adjustment settings 7. These parameters can facilitate mucus clearance without excessive barotrauma risk when used correctly.
Practical Application Algorithm
- Screen for pneumothorax: Perform chest imaging if any suspicion exists
- Assess hemodynamic stability: Ensure adequate blood pressure and cardiac output
- Check for active hemoptysis: If present, defer PEP therapy until controlled
- Verify tracheostomy patency: Ensure no obstruction or displacement
- Start with low resistance settings: Gradually increase based on tolerance 7
- Monitor continuously during initial sessions: Watch for adverse signs
Common Pitfalls to Avoid
- Do not use PEP devices during acute exacerbations with suspected pneumothorax - always image first if clinically indicated
- Do not assume all airway clearance techniques are contraindicated - aerosol therapies can continue even when PEP is contraindicated 1
- Do not use excessive pressures - start conservatively and titrate based on patient tolerance and sputum clearance effectiveness
The evidence strongly supports that pneumothorax is the primary contraindication requiring absolute avoidance of PEP therapy 1. In the absence of pneumothorax or severe hemodynamic compromise, the Acapella device can be safely and effectively used in chronically tracheostomized patients to improve airway clearance and quality of life.